FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280581185> ?p ?o ?g. }

• W4280581185 endingPage "135" @default.
• W4280581185 startingPage "125" @default.
• W4280581185 abstract "Liver fibrosis is caused by continuous wound healing responses to various harmful stimuli, including viral infection, drugs, alcohol, and autoimmune liver disease. The purpose of this study was to examine the effects of extracts of Periplaneta americana (EPA) in rats with pig serum-induced liver fibrosis to preliminarily assess the antifibrotic effect of EPA.Seventy rats were randomly divided into 7 groups (10 rats in each group): HC, the healthy control group; FC, the fibrotic control group; TL, low-dose EPA treatment group group; TM, medium-dose EPA group; TH, high-dose EPA treatment group; TC1, Panax notoginseng/Salvia mitiorrhiza treatment control group 1; TC2, colchicine treatment control group 2. TC1 and TC2 were used as the positive control to demonstrate the difference between EPA and the effects of other compounds. The liver fibrosis model was induced by intraperitoneal injection of 0.5 mL pig serum twice a week for 13 weeks in all groups except for the HC group. The hepatic fibrosis model was established at the 7th week, and followingly, the corresponding compounds were administered once a day in all groups for 6 weeks. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity was determined in rat blood serum. We also measured liver fibrosis-related serum markers, including hyaluronic acid (HA), mucin layer (LN), type III pre-collagen (PC-III) and type IV collagen (IV-C). Hematoxylin and eosin (H&E) and Masson stainings were used to assess liver morphology and determine the stage of fibrosis. Immunohistochemistry was used to detect the protein expression of NF-κB, α-smooth muscle actin (α-SMA), transforming growth factor-β1 (TGF-β1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in rat liver tissue.Compared with that of the HC group, the liver tissue of the FC group presented obvious liver damage and collagen deposition. The serum levels of ALT, AST, HA, LN, PC-Ⅲ and Ⅳ-C and the expression of NF-κB, α-SMA, TGF-β1 and TIMP-1 in the FC group were significantly higher than those in the HC group, the EPA treatment groups, the TC1 group and the TC2 group (P < 0.01). The levels of serum ALT, AST, HA, LN, PC-Ⅲ and Ⅳ-C and the expression of α-SMA, NF-κB, TGF-β1 and TIMP-1 in the TL, TC1 and TC2 groups were significantly higher than those TM and TH groups (P < 0.05). EPA treatment significantly improved liver function, decreased collagen deposition and reversed the pathological changes related to liver fibrosis.We found that EPA could reduce liver inflammation, suppress liver cell degeneration and necrosis, and reduce the formation of liver fibrous tissue. Its mechanism might be associated with inhibiting the expression of TGF-β1, TIMP-1, NF-κB and α-SMA to block signal transduction pathways in the hepatic fibrosis process. Therefore, EPA, as a traditional Chinese medicine, might be potentially used to prevent and treat hepatic fibrosis in the future. However, further more experiments are necessary to verify its effectiveness and possible signaling pathways." @default.
• W4280581185 created "2022-05-22" @default.
• W4280581185 creator A5000889459 @default.
• W4280581185 creator A5005542093 @default.
• W4280581185 creator A5018742393 @default.
• W4280581185 creator A5019007424 @default.
• W4280581185 creator A5038458086 @default.
• W4280581185 creator A5044757881 @default.
• W4280581185 creator A5072279396 @default.
• W4280581185 creator A5073156713 @default.
• W4280581185 creator A5083127826 @default.
• W4280581185 creator A5086132286 @default.
• W4280581185 creator A5090104276 @default.
• W4280581185 date "2022-06-30" @default.
• W4280581185 modified "2023-10-16" @default.
• W4280581185 title "Extracts of Periplaneta americana alleviate hepatic fibrosis by affecting hepatic TGF-β and NF-κB expression in rats with pig serum-induced liver fibrosis" @default.
• W4280581185 doi "https://doi.org/10.5603/fhc.a2022.0011" @default.
• W4280581185 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35575220" @default.
• W4280581185 hasPublicationYear "2022" @default.
• W4280581185 type Work @default.
• W4280581185 citedByCount "3" @default.
• W4280581185 countsByYear W42805811852022 @default.
• W4280581185 countsByYear W42805811852023 @default.
• W4280581185 crossrefType "journal-article" @default.
• W4280581185 hasAuthorship W4280581185A5000889459 @default.
• W4280581185 hasAuthorship W4280581185A5005542093 @default.
• W4280581185 hasAuthorship W4280581185A5018742393 @default.
• W4280581185 hasAuthorship W4280581185A5019007424 @default.
• W4280581185 hasAuthorship W4280581185A5038458086 @default.
• W4280581185 hasAuthorship W4280581185A5044757881 @default.
• W4280581185 hasAuthorship W4280581185A5072279396 @default.
• W4280581185 hasAuthorship W4280581185A5073156713 @default.
• W4280581185 hasAuthorship W4280581185A5083127826 @default.
• W4280581185 hasAuthorship W4280581185A5086132286 @default.
• W4280581185 hasAuthorship W4280581185A5090104276 @default.
• W4280581185 hasBestOaLocation W42805811851 @default.
• W4280581185 hasConcept C104317684 @default.
• W4280581185 hasConcept C105702510 @default.
• W4280581185 hasConcept C125473707 @default.
• W4280581185 hasConcept C126322002 @default.
• W4280581185 hasConcept C134018914 @default.
• W4280581185 hasConcept C142724271 @default.
• W4280581185 hasConcept C150194340 @default.
• W4280581185 hasConcept C176891718 @default.
• W4280581185 hasConcept C185592680 @default.
• W4280581185 hasConcept C204232928 @default.
• W4280581185 hasConcept C2776329913 @default.
• W4280581185 hasConcept C2777529286 @default.
• W4280581185 hasConcept C2779797417 @default.
• W4280581185 hasConcept C2780559512 @default.
• W4280581185 hasConcept C2780692422 @default.
• W4280581185 hasConcept C2993667909 @default.
• W4280581185 hasConcept C55493867 @default.
• W4280581185 hasConcept C71924100 @default.
• W4280581185 hasConceptScore W4280581185C104317684 @default.
• W4280581185 hasConceptScore W4280581185C105702510 @default.
• W4280581185 hasConceptScore W4280581185C125473707 @default.
• W4280581185 hasConceptScore W4280581185C126322002 @default.
• W4280581185 hasConceptScore W4280581185C134018914 @default.
• W4280581185 hasConceptScore W4280581185C142724271 @default.
• W4280581185 hasConceptScore W4280581185C150194340 @default.
• W4280581185 hasConceptScore W4280581185C176891718 @default.
• W4280581185 hasConceptScore W4280581185C185592680 @default.
• W4280581185 hasConceptScore W4280581185C204232928 @default.
• W4280581185 hasConceptScore W4280581185C2776329913 @default.
• W4280581185 hasConceptScore W4280581185C2777529286 @default.
• W4280581185 hasConceptScore W4280581185C2779797417 @default.
• W4280581185 hasConceptScore W4280581185C2780559512 @default.
• W4280581185 hasConceptScore W4280581185C2780692422 @default.
• W4280581185 hasConceptScore W4280581185C2993667909 @default.
• W4280581185 hasConceptScore W4280581185C55493867 @default.
• W4280581185 hasConceptScore W4280581185C71924100 @default.
• W4280581185 hasIssue "2" @default.
• W4280581185 hasLocation W42805811851 @default.
• W4280581185 hasLocation W42805811852 @default.
• W4280581185 hasOpenAccess W4280581185 @default.
• W4280581185 hasPrimaryLocation W42805811851 @default.
• W4280581185 hasRelatedWork W172224148 @default.
• W4280581185 hasRelatedWork W1974808961 @default.
• W4280581185 hasRelatedWork W2079829264 @default.
• W4280581185 hasRelatedWork W2126270623 @default.
• W4280581185 hasRelatedWork W2556903125 @default.
• W4280581185 hasRelatedWork W2595675480 @default.
• W4280581185 hasRelatedWork W2747640708 @default.
• W4280581185 hasRelatedWork W2917599433 @default.
• W4280581185 hasRelatedWork W4385477359 @default.
• W4280581185 hasRelatedWork W2471276791 @default.
• W4280581185 hasVolume "60" @default.
• W4280581185 isParatext "false" @default.
• W4280581185 isRetracted "false" @default.
• W4280581185 workType "article" @default.